Actively Recruiting
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea
Led by Novartis Pharmaceuticals · Updated on 2025-08-11
127
Participants Needed
11
Research Sites
161 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a prospective, open-label, multi-center, non-comparative, observational study to assess safety and effectiveness of Jakavi® (ruxolitinib) in the real-world clinical setting in Korean Graft-versus-Host disease (GvHD) patients
CONDITIONS
Official Title
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with Graft-versus-Host Disease (GvHD) and currently receiving or planned to receive Jakavi4 treatment according to local approval
- Willing to provide written informed consent before joining the study
You will not qualify if you...
- Under 12 years old
- Have contraindications as per the local approved Jakavi4 label
- Receiving or planning to receive any investigational medicine during the study observation period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
Novartis Investigative Site
Daegu, Dalseo gu, South Korea, 42602
Actively Recruiting
2
Novartis Investigative Site
Wŏnju, Gangwon-do, South Korea, 26426
Actively Recruiting
3
Novartis Investigative Site
Seoul, Seocho gu, South Korea, 06591
Actively Recruiting
4
Novartis Investigative Site
Busan, South Korea, 48108
Actively Recruiting
5
Novartis Investigative Site
Busan, South Korea, 49241
Actively Recruiting
6
Novartis Investigative Site
Busan, South Korea, 602-030
Actively Recruiting
7
Novartis Investigative Site
Jeollanam, South Korea, 519763
Actively Recruiting
8
Novartis Investigative Site
Jinju, South Korea, 660-702
Actively Recruiting
9
Novartis Investigative Site
Seoul, South Korea, 02841
Actively Recruiting
10
Novartis Investigative Site
Seoul, South Korea, 05505
Actively Recruiting
11
Novartis Investigative Site
Taegu, South Korea, 41944
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here